JUDITH BAKER: Open Payments
NPI 1639553639 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 15 payments from 11 companies in 2025. Trend: 2023 $289 · 2024 $203 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $62 |
| Edwards Lifesciences Corporation | 1 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Dexcom, Inc. | 1 | $25 |
| TOLMAR, INC. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: SHINGRIX, VOQUEZNA, XIFAXAN, Dexcom G6 Transmitter, JATENZO, GEMTESA, BEVESPI AEROSPHERE, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
